The Chaudry Laboratory is focused on the function of cyclin A2, a cell cycle regulator, in cardiac development and disease. Read More
Engineered Cardiac Tissue Developed to Study the Human Heart
February 2, 2014 - Researchers show their human engineered cardiac tissue may provide a reliable surrogate for human myocardium to improve preclinical therapeutic testing.
Long-Lasting Gene Therapy Benefits Advanced Heart Failure Patients
November 19, 2013 - Cardiovascular Research Center at Mount Sinai report promising long-term follow-up results for its single dose AAV1/SERCA2a gene therapy in advanced heart failure patients.